Skip to main content
. 2019 Feb 25;7(1):27. doi: 10.3390/diseases7010027

Figure 1.

Figure 1

The proposed role of probiotics in NAFLD therapy [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30]. ROS = reactive oxygen species; TMAO = trimethylamine N-oxide; FXR = farnesoid X receptor; TGR5 = G-protein coupled bile salt receptor 1; TLR = toll-like receptor; VLDL = very-low-density lipoprotein; NAFLD = non-alcoholic fatty liver disease; NASH = non-alcoholic steatohepatitis.